Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation.
Basadonna
G
G
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062.
Feria
A
A
Perez
R
R
Klein
H
H
Sturges
M
M
Colquhoun
S
S
D000212:Acyclovir / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000209:etiology* / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects; D008297:Male; D009894:Opportunistic Infections / Q000209:etiology; D012189:Retrospective Studies; D014777:Virus Diseases / Q000209:etiology
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin; D000212:Acyclovir